Most Read News

Ministry of Chemicals and Fertilizers has stated that there have been some media reports claiming shortage of fertilizers in Trichy, Tamil Nadu and Rajasthan. Such reports are beyond the facts. It is clarified that there is more than adequate availability of fertilizers in the country to meet the needs of Rabi season. Government of India is sending fertilizers as per need to all states, and […]

Eicher Motors appointed Vidhya Srinivasan as the chief financial officer (CFO) and key managerial personnel of the company with efffect from 18 November 2022.

Action taken after letter of complaint from Congress MP Karti Chidambaram

Indigo Paints shed 0.44% to Rs 1,340, extending its losing run for the fifth consecutive trading session.

Bajaj Healthcare announced the successfully competition of first ever pre approval inspection of United State Food and Drug Administration (USFDA) of its API facility located at Vadodara, Gujarat. The USFDA pre-approval inspection which was conducted from 14 November 2022 to 17 November 2022, ended with zero observations. Powered by Capital Market – Live News

Bhagwat Karad, Minister of State for Finance, Government of India yesterday said that the success of any developed or developing country depends on the quality of education, which is the core of everything. Addressing the ‘8th FICCI Higher Education Excellence Awards- 2022’, Karad said that technology also plays a critical role in the overall development of the country. He further urged the institutions to provide […]

Blue Dart rose 1.40% to Rs 7,258.50 after the company announced the opening of 25 retail outlets in tier I and II towns as part of its expansion plans.

Bank of Maharashtra, Nazara Technologies Ltd, Esab India Ltd and Indian Overseas Bank are among the other gainers in the BSEs A group today, 18 November 2022.

Biofil Chemicals & Pharmaceuticals Ltd, Vishal Bearings Ltd, Honda India Power Products Ltd and Oswal Agro Mills Ltd are among the other gainers in the BSEs B group today, 18 November 2022.

Aurobindo Pharma announced that its wholly owned subsidiary company, Eugia Pharma Specialities, has received a final approval from the US Food & Drug Administration (USFDA) for hotericin B Liposome for Injection, 50 mg. hotericin B Liposome for Injection, 50 mg/vial Single-Dose Vial to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), AmBisome Liposome for Injection, 50 mg/vial, of Astellas Pharma US, Inc.. […]